Lisa Romero1, Zipatly Mendoza2, Stacey Hurst3, Lauren B Zapata3, Rachel Powell2, Yari Vale4, Eva Lathrop5. 1. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, United States. Electronic address: eon1@cdc.gov. 2. National Foundation for the Centers for Disease Control and Prevention, United States. 3. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, United States. 4. University of Puerto Rico, Department of Gynecology and Obstetrics, United States. 5. Emory University, Department of Gynecology and Obstetrics, United States.
Abstract
OBJECTIVE: The Zika Contraception Access Network (Z-CAN) was a short-term emergency response intervention that used contraception to prevent unintended pregnancy to reduce Zika-related adverse birth outcomes during the 2016 2017 Zika virus outbreak in Puerto Rico. Strategies and safeguards were developed to ensure women who chose long-acting reversible contraception (LARC) had access to no-cost removal, if desired, after Z-CAN ended. STUDY DESIGN: We assessed the number of women who chose LARC at their initial Z-CAN visit who filed complaints regarding challenges with LARC removal within 30-months after the Z-CAN program ended. Complaints and program responses were categorized. RESULTS: Of the 29,221 women who received Z-CAN services, 20,381 chose a LARC method at their initial visit (IUD = 12,276 and implant = 8105). Between September 2017 and February 2020, 63 patient complaints were logged, mostly due to LARC removal charges (76.2%) which were generally (71.4%) determined to be inappropriate charges. All complaints filed were resolved allowing LARC removal within an average of 28 days. CONCLUSION: Safeguards to ensure prompt LARC removal when desired are critical to ensure women s reproductive autonomy. IMPLICATIONS: Strategies and safeguards used by Z-CAN to ensure women have access to LARC removal might be used by other contraception programs to prevent reproductive coercion and promote reproductive autonomy to best meet the reproductive needs of women. Published by Elsevier Inc.
OBJECTIVE: The Zika Contraception Access Network (Z-CAN) was a short-term emergency response intervention that used contraception to prevent unintended pregnancy to reduce Zika-related adverse birth outcomes during the 2016 2017 Zika virus outbreak in Puerto Rico. Strategies and safeguards were developed to ensure women who chose long-acting reversible contraception (LARC) had access to no-cost removal, if desired, after Z-CAN ended. STUDY DESIGN: We assessed the number of women who chose LARC at their initial Z-CAN visit who filed complaints regarding challenges with LARC removal within 30-months after the Z-CAN program ended. Complaints and program responses were categorized. RESULTS: Of the 29,221 women who received Z-CAN services, 20,381 chose a LARC method at their initial visit (IUD = 12,276 and implant = 8105). Between September 2017 and February 2020, 63 patient complaints were logged, mostly due to LARC removal charges (76.2%) which were generally (71.4%) determined to be inappropriate charges. All complaints filed were resolved allowing LARC removal within an average of 28 days. CONCLUSION: Safeguards to ensure prompt LARC removal when desired are critical to ensure women s reproductive autonomy. IMPLICATIONS: Strategies and safeguards used by Z-CAN to ensure women have access to LARC removal might be used by other contraception programs to prevent reproductive coercion and promote reproductive autonomy to best meet the reproductive needs of women. Published by Elsevier Inc.
Authors: Aline C Gubrium; Emily S Mann; Sonya Borrero; Christine Dehlendorf; Jessica Fields; Arline T Geronimus; Anu M Gómez; Lisa H Harris; Jenny A Higgins; Katrina Kimport; Kristin Luker; Zakiya Luna; Laura Mamo; Dorothy Roberts; Diana Romero; Gretchen Sisson Journal: Am J Public Health Date: 2015-11-12 Impact factor: 9.308
Authors: Lisa Romero; Lisa M Koonin; Lauren B Zapata; Stacey Hurst; Zipatly Mendoza; Eva Lathrop Journal: Am J Public Health Date: 2018-09 Impact factor: 9.308
Authors: Samantha M Olson; Augustina Delaney; Abbey M Jones; Christopher P Carr; Rebecca F Liberman; Nina E Forestieri; Van T Tong; Suzanne M Gilboa; Margaret A Honein; Cynthia A Moore; Janet D Cragan Journal: Birth Defects Res Date: 2019-07-02 Impact factor: 2.344
Authors: Naomi K Tepper; Howard I Goldberg; Manuel I Vargas Bernal; Brenda Rivera; Meghan T Frey; Claritsa Malave; Christina M Renquist; Nabal Jose Bracero; Kenneth L Dominguez; Ramon E Sanchez; Carrie K Shapiro-Mendoza; Blanca R Cuevas Rodriguez; Regina M Simeone; Nicki T Pesik; Wanda D Barfield; Jean Y Ko; Romeo R Galang; Janice Perez-Padilla; Kara N D Polen; Margaret A Honein; Sonja A Rasmussen; Denise J Jamieson Journal: MMWR Morb Mortal Wkly Rep Date: 2016-04-01 Impact factor: 17.586
Authors: Eva Lathrop; Lisa Romero; Stacey Hurst; Nabal Bracero; Lauren B Zapata; Meghan T Frey; Maria I Rivera; Erin N Berry-Bibee; Margaret A Honein; Judith Monroe; Denise J Jamieson Journal: Lancet Public Health Date: 2018-01-19
Authors: Rui Li; Sascha R Ellington; Romeo R Galang; Scott D Grosse; Zipatly Mendoza; Stacey Hurst; Yari Vale; Eva Lathrop; Lisa Romero Journal: Contraception Date: 2021-11-05 Impact factor: 3.375